Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru

[1]  E. Gotuzzo,et al.  Genotyping of potentially pathogenic Acanthamoeba strains isolated from nasal swabs of healthy individuals in Peru. , 2014, Acta tropica.

[2]  T. Nerad,et al.  Characterization of a New Pathogenic Acanthamoeba Species, A. byersi n. sp., Isolated from a Human with Fatal Amoebic Encephalitis , 2013, The Journal of eukaryotic microbiology.

[3]  A. López-Arencibia,et al.  Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4]  A. López-Arencibia,et al.  Activity assessment of Tunisian olive leaf extracts against the trophozoite stage of Acanthamoeba , 2013, Parasitology Research.

[5]  A. López-Arencibia,et al.  Acanthamoeba keratitis: an emerging disease gathering importance worldwide? , 2013, Trends in parasitology.

[6]  A. Mir,et al.  Evaluation of inhibitory potential of some selective methanolic plants extracts on biological characteristics of Acanthamoeba castellanii using human corneal epithelial cells in vitro , 2013, Parasitology Research.

[7]  R. López-Vélez,et al.  Successful monitoring and treatment of intraocular dissemination of acanthamoeba. , 2012, Archives of ophthalmology.

[8]  K. Ismail,et al.  In vitro amoebicidal activity of ethanol extracts of Arachis hypogaea L., Curcuma longa L. and Pancratium maritimum L. on Acanthamoeba castellanii cysts , 2012, Parasitology Research.

[9]  Naveed Ahmed Khan,et al.  Biology and pathogenesis of Acanthamoeba , 2012, Parasites & Vectors.

[10]  E. Malatyalı,et al.  In vitro amoebicidal activity of four Peucedanum species on Acanthamoeba castellanii cysts and trophozoites , 2011, Parasitology Research.

[11]  E. Edell,et al.  Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis. , 2010, American journal of ophthalmology.

[12]  Marcos Ñavincopa,et al.  Cutaneous acanthamebiasis infection in immunocompetent and immunocompromised patients , 2009, International journal of dermatology.

[13]  C. Martín-Navarro,et al.  Isolation and genotyping of potentially pathogenic Acanthamoeba strains from dust sources in Iran. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  M. Derda,et al.  Plant extracts as natural amoebicidal agents , 2009, Parasitology Research.

[15]  Basilio Valladares,et al.  The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain. , 2008, Journal of medical microbiology.

[16]  M. Rott,et al.  In vitro evaluation of the amebicidal activity of Pterocaulon polystachyum (Asteraceae) against trophozoites of Acanthamoeba castellanii , 2008, Parasitology Research.

[17]  L. Kubatko,et al.  Efficacy of Contact Lens Systems Against Recent Clinical and Tap Water Acanthamoeba Isolates , 2008, Journal of acquired immune deficiency syndromes.

[18]  J. Lorenzo-Morales,et al.  Glycogen Phosphorylase in Acanthamoeba spp.: Determining the Role of the Enzyme during the Encystment Process Using RNA Interference , 2008, Eukaryotic Cell.

[19]  C. Bunce,et al.  Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. , 2008, American journal of ophthalmology.

[20]  Z. Polat,et al.  In vitro effectiveness of Thymus sipyleus subsp. sipyleus var. sipyleus on Acanthamoeba castellanii and its cytotoxic potential on corneal cells , 2007, Parasitology Research.

[21]  J. Montoya,et al.  A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient , 2007, Transplant infectious disease : an official journal of the Transplantation Society.

[22]  N. Khan.  Acanthamoeba: biology and increasing importance in human health. , 2006, FEMS microbiology reviews.

[23]  F. Schuster,et al.  In‐Vitro Activity of Miltefosine and Voriconazole on Clinical Isolates of Free‐Living Amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri , 2006, The Journal of eukaryotic microbiology.

[24]  J. Lorenzo-Morales,et al.  RNA interference (RNAi) for the silencing of extracellular serine proteases genes in Acanthamoeba: molecular analysis and effect on pathogenecity. , 2005, Molecular and biochemical parasitology.

[25]  A. Maghsood,et al.  Acanthamoeba genotype T4 from the UK and Iran and isolation of the T2 genotype from clinical isolates. , 2005, Journal of medical microbiology.

[26]  高久 洋.  RNA interference (RNAi) による遺伝子治療 , 2005 .

[27]  F. Schuster,et al.  Opportunistic amoebae: challenges in prophylaxis and treatment. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[28]  N. Khan.  Pathogenesis of Acanthamoeba infections. , 2003, Microbial pathogenesis.

[29]  G. Cabral,et al.  Acanthamoeba spp. as Agents of Disease in Humans , 2003, Clinical Microbiology Reviews.

[30]  Ivan A. Ross.  Curcuma longa L. , 2003 .

[31]  B. Na,et al.  Characterization and pathogenetic role of proteinase from Acanthamoeba castellanii. , 2001, Microbial pathogenesis.

[32]  N. Khan,et al.  Proteases as Markers for Differentiation of Pathogenic and Nonpathogenic Species ofAcanthamoeba , 2000, Journal of Clinical Microbiology.

[33]  J. Leysen,et al.  Novel computational model for the interaction of dopamine with the D2 receptor. , 1993, Receptors & channels.

[34]  D. S. Bhakuni,et al.  Sterols of Acanthamoeba culbertsoni strain A-1 , 1988, Steroids.

[35]  A. Martínez,et al.  Is Acanthamoeba encephalitis an opportunistic infection? , 1980, Neurology.

[36]  E. Korn,et al.  7-Dehydrostigmasterol and ergosterol: the major sterols of an amoeba. , 1968, Journal of lipid research.

[37]  A. Uslar-Pietri.  Alexander von Humboldt. , 1963 .